Advanced search
Publication Cover
Scandinavian Journal of Urology Volume 56, 2022 - Issue 1
Journal homepage
276
Views
0
CrossRef citations to date
0
Altmetric
Articles

The safety and effectiveness of mirabegron in Parkinson’s disease patients with overactive bladder: a randomized controlled trial

Mohamad Moussaa Urology Department, Zahraa Hospital, University Medical Center, Lebanese University, Beirut, Lebanon
,
Mohamad Abou Chakrab Faculty of Medicine, Urology Department, Lebanese University, Beirut, LebanonCorrespondence[email protected]
,
Baraa Dabboucyc Department of Neurosurgery, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon
,
Youssef Faresd Department of Neurosurgery, Neuroscience Research Center, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon
,
Athanasios Dellise Department of Urology/General Surgery, Areteion Hospital, Athens, Greece
&
Athanasios Papatsorisf 2nd Department of Urology, School of Medicine, Sismanoglio Hospital, National and Kapodistrian University of Athens, Athens, Greece
Pages 66-72 | Received 20 May 2021, Accepted 04 Oct 2021, Published online: 21 Oct 2021

References

  • Sakakibara R, Uchiyama T, Yamanishi T, et al. Bladder and bowel dysfunction in parkinson’s disease. J Neural Transm (Vienna). 2008;115(3):443–460.
  • Sakakibara R, Panicker J, Finazzi-Agro E, et al. A guideline for the management of bladder dysfunction in Parkinson’s disease and other gait disorders. Neurourol Urodyn. 2016;35(5):551–563.
  • Sakakibara R, Tateno F, Kishi M, et al. Pathophysiology of bladder dysfunction in Parkinson’s disease. Neurobiol Dis. 2012;46(3):565–571.
  • Sakakibara R, Tateno F, Nagao T, et al. Bladder function of patients with Parkinson’s disease. Int J Urol. 2014;21(7):638–646.
  • Hajebrahimi S, Chapple CR, Pashazadeh F, et al. Management of neurogenic bladder in patients with Parkinson’s disease: a systematic review. Neurourol Urodyn. 2019;38(1):31–62.
  • Krhut J, Borovička V, Bílková K, et al. Efficacy and safety of mirabegron for the treatment of neurogenic detrusor overactivity-prospective, randomized, double-blind, placebo-controlled study. Neurourol Urodyn. 2018;37(7):2226–2233.
  • Reichmann H. Clinical criteria for the diagnosis of Parkinson’s disease. Neurodegener Dis. 2010;7(5):284–290.
  • Goetz CG, Poewe W, Rascol O, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord. 2004;19(9):1020–1028.
  • Homma Y, Yoshida M, Seki N, et al. Symptom assessment tool for overactive bladder syndrome–overactive bladder symptom score. Urology. 2006;68(2):318–323.
  • Coyne KS, Thompson CL, Lai JS, et al. An overactive bladder symptom and health-related quality of life short-form: validation of the OAB-q SF. Neurourol Urodyn. 2015;34(3):255–263.
  • Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129–2170.
  • Gotoh M, Homma Y, Yokoyama O, et al. Responsiveness and minimal clinically important change in overactive bladder symptom score. Urology. 2011;78(4):768–773.
  • Coyne KS, Matza LS, Thompson CL, et al. Determining the importance of change in the overactive bladder questionnaire. J Urol. 2006;176(2):627–632.
  • Walter U, Dressler D, Wolters A, et al. Overactive bladder in Parkinson’s disease: alteration of brainstem raphe detected by transcranial sonography. Eur J Neurol. 2006;13(12):1291–1297.
  • Soebadi MA, Hakim L, Van der Aa F, et al. Real-life data on mirabegron in neurogenic bladder dysfunction. Urol Int. 2019;103(2):195–201.
  • El Helou E, Labaki C, Chebel R, et al. The use of mirabegron in neurogenic bladder: a systematic review. World J Urol. 2020; 38(10):2435–2442.
  • Peyronnet B, Vurture G, Palma JA, et al. Mirabegron in patients with Parkinson disease and overactive bladder symptoms: a retrospective cohort. Parkinsonism Relat Disord. 2018;57:22–26.
  • Gubbiotti M, Conte A, Di Stasi SM, et al. Feasibility of mirabegron in the treatment of overactive bladder in patients affected by Parkinson’s disease: a pilot study. Ther Adv Neurol Disord. 2019;12:1756286419843458.
  • Cho SY, Jeong SJ, Lee S, et al. Mirabegron for treatment of overactive bladder symptoms in patients with Parkinson’s disease: a double-blind, randomized placebo-controlled trial (Parkinson’s Disease Overactive bladder Mirabegron, PaDoMi Study). Neurourol Urodyn. 2021;40(1):286–294.
  • Zesiewicz TA, Evatt M, Vaughan CP, et al. Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson’s disease. Parkinsonism Relat Disord. 2015;21(5):514–520.
  • Yonguc T, Sefik E, Inci I, et al. Randomized, controlled trial of fesoterodine fumarate for overactive bladder in Parkinson’s disease. World J Urol. 2020;38(8):2013–2019.
  • Chapple CR, Cruz F, Cardozo L, et al. Safety and efficacy of mirabegron: analysis of a large integrated clinical trial database of patients with overactive bladder receiving mirabegron, antimuscarinics, or placebo. Eur Urol. 2020;77(1):119–128.
  • Rosa GM, Ferrero S, Nitti VW, et al. Cardiovascular safety of β3-adrenoceptor agonists for the treatment of patients with overactive bladder syndrome. Eur Urol. 2016; 69(2):311–323.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.